Clinical Trial Update: Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the combination of E7070 and capecitabine in patients with metastatic colorectal cancer to determine efficacy and the recommended dose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• E7070
• Xeloda (capecitabine)

Snippet

Sponsor: Eisai Limited | Conditions: Colorectal Cancer (CRC) | Phase 2 | Status: COMPLETED